|
2024 |
2023 |
|||||||
(dollars in millions) |
Q3 |
Q2 |
Q3 |
||||||
Adjusted EBITDA |
$ |
35.2 |
|
$ |
31.9 |
|
$ |
45.4 |
|
Divided by Total Net Sales |
|
210.3 |
|
|
214.2 |
|
|
229.1 |
|
Adjusted EBITDA Margin |
|
16.7 |
% |
|
14.9 |
% |
|
19.8 |
% |
*Values in table may not add due to rounding. |
|||||||||
Reconciliation of Net Cash Provided By (Used In) Operating Activities to Free Cash Flow*:
|
2024 |
2023 |
|||||||
(dollars in millions) |
Q3 |
Q2 |
Q3 |
||||||
Net Cash Provided By Operating Activities |
$ |
42.4 |
|
$ |
22.9 |
|
$ |
42.0 |
|
Non-Acquisition Capital Expenditures |
|
(17.2 |
) |
|
(14.1 |
) |
|
(6.7 |
) |
Free Cash Flow |
$ |
25.2 |
|
$ |
8.8 |
|
$ |
35.3 |
|
*Values in table may not add due to rounding. |
|||||||||
